LogiPharma US 2014 (past event)
September 16 - 18, 2014
Westin Princeton, Princeton, NJ
Contact Us: 1.888.482.6012
Feargal Mc Groarty
Project Manager, NCHCH
St. James Hospital
Check out the incredible speaker line-up to see who will be joining Feargal.
Download The Latest AgendaDay 1
Thursday, April 9th, 2015
14:10 Leveraging Data From 2D Matrix Barcodes To Enhance Decision Making, Build Brand Loyalty & Increase Compliance
Unlike any other time in history we now have mobile technology that can be leveraged to provide the tools required to implement initiatives that can improve supply chain security, increase patient safety, reduce costs and support a rapid real time medication recall. A smartphone application and a serialized datamatrix (GS1) barcode on medication packaging can be used track and trace medication in real time to monitor compliance, optimize supply chain efficiency, help identify counterfeits and reduce costs. This session will present a real-life case study covering:
• Ensuring the medication is always available for patients
• Helping prevent counterfeit medication entering the supply chain using medication serialization
• Minimizing waste medication (it is expensive!)
• Assisting in forecasting
• Building Brand Loyalty
• Complying with GMP/ GCP conditions such as expiry date management and accountability
• Complying with upcoming EU and US regulatory requirements
• Providing immediate real-time location of all medication (Track and Trace) in the event of a recall, including identifying who may have received an at risk product
• Ensuring the medication is always available for patients
• Helping prevent counterfeit medication entering the supply chain using medication serialization
• Minimizing waste medication (it is expensive!)
• Assisting in forecasting
• Building Brand Loyalty
• Complying with GMP/ GCP conditions such as expiry date management and accountability
• Complying with upcoming EU and US regulatory requirements
• Providing immediate real-time location of all medication (Track and Trace) in the event of a recall, including identifying who may have received an at risk product